These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1310076)

  • 1. Skin kinetics of azole antifungal drugs.
    Cauwenbergh G
    Curr Top Med Mycol; 1992; 4():88-136. PubMed ID: 1310076
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic profile of orally administered itraconazole in human skin.
    Cauwenbergh G; Degreef H; Heykants J; Woestenborghs R; Van Rooy P; Haeverans K
    J Am Acad Dermatol; 1988 Feb; 18(2 Pt 1):263-8. PubMed ID: 2831254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of oral antifungals and their clinical implications.
    Heykants J; Van Peer A; Lavrijsen K; Meuldermans W; Woestenborghs R; Cauwenbergh G
    Br J Clin Pract Suppl; 1990 Sep; 71():50-6. PubMed ID: 1965419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects.
    Van Peer A; Woestenborghs R; Heykants J; Gasparini R; Gauwenbergh G
    Eur J Clin Pharmacol; 1989; 36(4):423-6. PubMed ID: 2544431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of oral itraconazole in AIDS patients.
    Smith D; van de Velde V; Woestenborghs R; Gazzard BG
    J Pharm Pharmacol; 1992 Jul; 44(7):618-9. PubMed ID: 1357148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administration.
    Schäfer-Korting M; Korting HC; Lukacs A; Heykants J; Behrendt H
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):211-5. PubMed ID: 2155951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azole antifungal drugs: old and new.
    Dismukes WE
    Ann Intern Med; 1988 Aug; 109(3):177-9. PubMed ID: 2839058
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral itraconazole versus topical bifonazole treatment in experimental dermatophytosis.
    Borgers M; Xhonneux B; Van Cutsem J
    Mycoses; 1993; 36(3-4):105-15. PubMed ID: 8396203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical pharmacokinetics of itraconazole: an overview.
    Heykants J; Van Peer A; Van de Velde V; Van Rooy P; Meuldermans W; Lavrijsen K; Woestenborghs R; Van Cutsem J; Cauwenbergh G
    Mycoses; 1989; 32 Suppl 1():67-87. PubMed ID: 2561187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral, topical and parenteral antifungal treatment with itraconazole in normal and in immunocompromised animals.
    Van Cutsem J
    Mycoses; 1989; 32 Suppl 1():14-34. PubMed ID: 2561183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The triazole antifungal agents: a review of itraconazole and fluconazole.
    Bailey EM; Krakovsky DJ; Rybak MJ
    Pharmacotherapy; 1990; 10(2):146-53. PubMed ID: 2161523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral itraconazole therapy for disseminated candidiasis in low birth weight infants.
    Bhandari V; Narang A
    J Pediatr; 1992 Feb; 120(2 Pt 1):330. PubMed ID: 1310508
    [No Abstract]   [Full Text] [Related]  

  • 13. Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studies.
    Liu L; Bello A; Dresser MJ; Heald D; Komjathy SF; O'Mara E; Rogge M; Stoch SA; Robertson SM
    J Clin Pharmacol; 2016 Feb; 56(2):143-51. PubMed ID: 26044116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of itraconazole following oral administration to normal volunteers.
    Hardin TC; Graybill JR; Fetchick R; Woestenborghs R; Rinaldi MG; Kuhn JG
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1310-3. PubMed ID: 2848442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of paracoccidioidomycosis and histoplasmosis by oral itraconazole].
    Negroni R; Palmieri OJ; Chá Torea JC
    Medicina (B Aires); 1987; 47(5):505-8. PubMed ID: 2849706
    [No Abstract]   [Full Text] [Related]  

  • 16. Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis.
    Willemsen M; De Doncker P; Willems J; Woestenborghs R; Van de Velde V; Heykants J; Van Cutsem J; Cauwenbergh G; Roseeuw D
    J Am Acad Dermatol; 1992 May; 26(5 Pt 1):731-5. PubMed ID: 1316389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of animal and human pharmacology in antifungal drug design.
    Cauwenbergh G; Van Cutsem J
    Ann N Y Acad Sci; 1988; 544():264-9. PubMed ID: 2850750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Itraconazole concentrations in airway fluid and tissue.
    Watkins DN; Badcock NR; Thompson PJ
    Br J Clin Pharmacol; 1992 Feb; 33(2):206-7. PubMed ID: 1312855
    [No Abstract]   [Full Text] [Related]  

  • 19. Serologic response to itraconazole in allergic bronchopulmonary aspergillosis.
    Pacheco A; Martin JA; Cuevas M
    Chest; 1993 Mar; 103(3):980-1. PubMed ID: 8383593
    [No Abstract]   [Full Text] [Related]  

  • 20. [Itraconazole in systemic fungal infections].
    Denning DW
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():3-4. PubMed ID: 1663203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.